Oruka Therapeutics's total assets for Q1 2026 were $504.48M, an increase of 3.25% from the previous quarter. ORKA total liabilities were $17.76M for the fiscal quarter, a 6.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.